V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007953 | 250005502 | 0 | 100 | Disease modification (D) | 2018-01-27 | 2018-01-27 | TEMOZOLOMIDE | N | N | 250006527 | AZACITIDINE |
| 250007954 | 250005503 | 1.87 | 56.4 | Palliative (P) | 2016-04-22 | 2016-04-27 | Vinorelbine (oral) | N | N | 250006603 | CHLORAMBUCIL |
| 250007955 | 250005503 | null | 78.4 | Curative (C) | 2016-06-05 | 2016-06-05 | Carboplatin + Etoposide iv&po | 99 | N | 250006603 | CYTARABINE |
| 250007956 | 250011664 | null | null | Adjuvant (A) | 2013-10-19 | 2013-10-19 | Trial Unspecified | N | null | 250006714 | NOT MATCHED |
| 250007957 | 250005504 | 1.69 | 0 | Adjuvant (A) | 2018-11-12 | 2018-12-08 | IPM | N | N | 250006726 | GEMCITABINE |
| 250007958 | 250005505 | 1.66 | 8.2 | Palliative (P) | 2013-04-12 | 2013-05-09 | Azacitidine | N | N | 250006850 | CISPLATIN + PACLITAXEL |
| 250007959 | 250005505 | 1.64 | 52.5 | null | 2016-05-31 | 2016-06-15 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250006850 | GEMCARBO |
| 250007960 | 250005506 | null | 92.5 | null | 2015-08-08 | 2015-08-12 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | 250006933 | CARBOPLATIN + ETOPOSIDE |
| 250007961 | 250005507 | 1.75 | 77.3 | Palliative (P) | null | 2014-04-18 | GEMCARBO | 2 | N | 250006939 | CARBOPLATIN |
| 250007962 | 250005507 | null | null | Adjuvant (A) | 2018-04-30 | 2018-04-30 | Trial Unspecified | 01 | null | 250006939 | TRIAL |
| 250007963 | 250005507 | null | null | Disease modification (D) | 2016-10-26 | 2016-11-17 | Cisplatin | N | N | 250006939 | PILOT TRIAL |
| 250007964 | 250005508 | 1.59 | null | Disease modification (D) | 2015-02-04 | 2015-02-04 | DA 3 + 10 | N | N | 250007196 | CAPECITABINE |
| 250007965 | 250005509 | 1.62 | 73 | Palliative (P) | 2018-01-19 | 2018-01-19 | Carboplatin + Paclitaxel (weekly) | 2 | N | 250007231 | CYTARABINE |
| 250007966 | 250005509 | 1.65 | 76.5 | null | 2015-03-20 | 2015-03-20 | CYTARABINE | null | N | 250007231 | CHOP R |
| 250007967 | 250005509 | 1.84 | 77.3 | null | null | 2015-04-21 | MYELOMA XI TRIAL | null | null | 250007231 | PEMBROLIZUMAB |
| 250007968 | 250005510 | 1.74 | 72.6 | Adjuvant (A) | 2014-07-26 | 2014-08-03 | GemCarbo Days 1+8 | N | N | 250007319 | TRIAL |
| 250007969 | 250009883 | 1.82 | 0 | Palliative (P) | null | 2016-08-12 | FIGARO TRIAL | N | N | 250007336 | GEMCARBO |
| 250007970 | 250005511 | 0 | 0 | Disease modification (D) | null | 2017-06-09 | Pemetrexed | N | N | 250007396 | TRIAL |
| 250007971 | 250005511 | 1.45 | 62.5 | Curative (C) | null | 2016-07-29 | Trial Unspecified | null | N | 250007396 | RITUXIMAB |
| 250007972 | 250005511 | 1.8 | 73 | Adjuvant (A) | 2017-09-12 | 2017-09-12 | Vinorelbine (oral) | 02 | null | 250007396 | PEMETREXED |
| 250007973 | 250012409 | null | 57.35 | Palliative (P) | 2018-11-30 | 2018-11-30 | Carboplatin + Vinorelbine Oral | N | N | 250007536 | AFLIBERCEPT + FU + IRINOTECAN |
| 250007974 | 250012719 | null | 54.8 | Palliative (P) | null | 2017-01-19 | Trial Unspecified | null | N | 250007606 | AFLIBERCEPT + FU + IRINOTECAN |
| 250007975 | 250005512 | 1.69 | null | Palliative (P) | 2018-09-25 | 2018-10-05 | Pemetrexed | N | N | 250007628 | TRIAL |
| 250007976 | 250005512 | 1.68 | null | Palliative (P) | 2013-11-29 | 2013-11-29 | Melphalan oral | N | N | 250007628 | IPM |
| 250007977 | 250011668 | 1.8 | 58.9 | null | 2016-05-05 | 2016-05-08 | Doxorubicin + Olaratumab | null | null | 250007692 | PEMETREXED |
| 250007978 | 250005513 | 1.54 | 76 | Disease modification (D) | 2018-02-14 | 2018-02-17 | CHOP R - 21 days | N | N | 250007814 | ABVD |
| 250007979 | 250005514 | 1.8 | 68 | Neo-adjuvant (N) | 2017-06-12 | 2017-06-20 | GEMCARBO | N | N | 250007836 | TRIAL |
| 250007980 | 250005514 | 1.67 | null | Curative (C) | 2016-01-26 | 2016-01-26 | GemCarbo Days 1+8 | 99 | N | 250007836 | FLAG |
| 250007981 | 250011669 | 1.82 | null | Disease modification (D) | 2012-12-23 | 2012-12-31 | Pemetrexed | N | N | 250007943 | TRIAL |
| 250007982 | 250011669 | null | 0 | Curative (C) | 2016-08-03 | 2016-08-18 | Erlotinib | N | N | 250007943 | NOT MATCHED |
| 250007983 | 250005515 | 1.51 | null | null | 2018-03-07 | 2018-03-07 | Trial Unspecified | 2 | N | 250007990 | FLUOROURACIL + RT |
| 250007984 | 250005516 | null | 0 | Disease modification (D) | 2016-01-16 | 2016-02-12 | DA 3 + 10 | N | N | 250008051 | TRIAL |
| 250007985 | 250005516 | 1.78 | null | Palliative (P) | 2015-02-22 | 2015-02-22 | Vinorelbine (oral) | null | N | 250008051 | IPM |
| 250007986 | 250005516 | 0 | 76 | Palliative (P) | 2017-01-29 | 2017-02-06 | Vinorelbine (oral) | 2 | N | 250008051 | CISPLATIN + PACLITAXEL |
| 250007987 | 250005516 | 1.74 | null | Palliative (P) | 2013-10-17 | 2013-10-31 | Trial Unspecified | 2 | null | 250008051 | CYTARABINE |
| 250007988 | 250005516 | 1.77 | 63.8 | Disease modification (D) | 2016-04-09 | 2016-04-09 | Trial Unspecified | N | N | 250008051 | TRIAL |
| 250007989 | 250005517 | 1.65 | 75 | Adjuvant (A) | null | 2016-12-29 | CHOP R | N | N | 250008208 | TRIAL |
| 250007990 | 250005518 | null | null | null | 2012-11-22 | 2013-01-25 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250008267 | GEMCARBO |
| 250007991 | 250005519 | null | 67.6 | null | 2014-06-13 | 2014-06-24 | Trial Unspecified | 2 | N | 250008293 | CAPECITABINE + OXALIPLATIN |
| 250007992 | 250005520 | 0 | null | Disease modification (D) | 2018-05-05 | 2018-05-12 | Vinorelbine (oral) | N | N | 250008320 | CHOP R |
| 250007993 | 250005520 | 1.74 | 101.6 | Palliative (P) | null | 2015-12-15 | ECarboX | null | N | 250008320 | AFLIBERCEPT + FU + IRINOTECAN |
| 250007994 | 250005520 | 1.86 | 78 | Adjuvant (A) | 2013-08-12 | 2013-08-12 | Pemetrexed | null | N | 250008320 | TRIAL |
| 250007995 | 250005521 | 1.78 | 113.3 | Palliative (P) | 2014-12-13 | 2014-12-13 | Pemetrexed | 02 | N | 250008353 | RUXOLITINIB |
| 250007996 | 250005521 | 0 | 59.3 | Palliative (P) | 2014-10-08 | 2014-10-18 | Chlorambucil | 2 | N | 250008353 | DA |
| 250007997 | 250005522 | 1.5 | 72.3 | Palliative (P) | 2016-05-09 | 2016-05-10 | EOX | 2 | N | 250008425 | TRIAL |
| 250007998 | 250005523 | 1.87 | 81 | Curative (C) | 2018-08-07 | 2018-08-08 | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 01 | N | 250008446 | CYTARABINE |
| 250007999 | 250005523 | 1.62 | 59.8 | Disease modification (D) | null | 2016-05-02 | AML 18 TRIAL | N | N | 250008446 | ETOPOSIDE + LOMUSTINE + VINCRISTINE |
| 250008000 | 250005524 | null | 59.5 | Disease modification (D) | 2017-08-02 | 2017-08-17 | Pemetrexed | 1 | N | 250008458 | PEMETREXED |
| 250008001 | 250005524 | 0 | 91.8 | Palliative (P) | 2016-04-01 | 2016-04-01 | IPM | Y | N | 250008458 | CAPECITABINE + OXALIPLATIN |
| 250008002 | 250005524 | 1.59 | null | Palliative (P) | 2012-04-21 | 2018-11-02 | Pemetrexed | N | N | 250008458 | DOCETAXEL |